Tag Archives: Certain

Was COVID a Bioweapon That Targets Certain Races?

According to mainstream media, Presidential candidate Robert F. Kennedy Jr. recently made claims about COVID-19 being an ethnically targeted bioweapon. Yahoo! News,1 for example, reported that “Robert F. Kennedy Jr. baselessly claimed COVID-19 may have been ‘ethnically targeted’ … He said Caucasians and black people were most susceptible, and Ashkenazi Jews and Chinese people were… Read More »

FDA Approves Retevmo for Certain Lung, Thyroid Cancers

MONDAY, May 11, 2020 — Retevmo (selpercatinib) capsules have been approved to treat patients with non-small cell lung cancer (NSCLC), medullary thyroid cancer (MTC), and other thyroid cancers with an alteration in the “rearranged during transfection” (RET) gene, the U.S. Food and Drug Administration announced Friday. Retevmo was approved for adults with metastatic NSCLC and… Read More »

Hispanics in Certain Counties More Likely to Die from Heart Disease, Stroke

(Juanmonino/Getty Images) Hispanic adults who live in counties with high concentrations of their ethnic peers are about 60 percent more likely than those who don’t to die from heart disease and stroke, a new study shows. As a group, Hispanics have lower death rates from heart disease and stroke than white and black adults –… Read More »

FDA Approves Keytruda (pembrolizumab) plus Lenvima (lenvatinib) Combination Treatment for Patients with Certain Types of Endometrial Carcinoma

Print this page KENILWORTH, N.J., & WOODCLIFF LAKE, N.J.– September 17, 2019 — (BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Eisai today announced that the U.S. Food and Drug Administration (FDA) approved the combination of Keytruda, Merck’s anti-PD-1 therapy, plus Lenvima, the orally available kinase inhibitor discovered by… Read More »

FDA Approves Jatenzo (testosterone undecanoate) for Certain Forms of Hypogonadism

FDA Approves Jatenzo (testosterone undecanoate) for Certain Forms of Hypogonadism Print this page March 27, 2019 — The U.S. Food and Drug Administration today approved Jatenzo (testosterone undecanoate), an oral testosterone capsule to treat men with certain forms of hypogonadism. These men have low testosterone levels due to specific medical conditions, such as genetic disorders… Read More »